How severe is CVE-2020-27272?

CVE-2020-27272 has a CVSS 3.x base score of 5.7, rated medium severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is high, integrity none, and availability none.

Is CVE-2020-27272 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (37th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2020-27272?

CVE-2020-27272 primarily affects Sooil Anydana-a Firmware. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2020-27272?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2020-27272 published?

CVE-2020-27272 was published on 2021-01-19 and last updated on 2026-06-17.

CVE-2020-27272

CVE-2020-27272 is a medium-severity vulnerability in Sooil Anydana-a Firmware with a CVSS 3.x base score of 5.7. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Severity: Medium (CVSS 3.x base score 5.7)
CVSS v2: 2.9
EPSS exploit prediction: 0% (37th percentile)
Actively exploited: Not listed in CISA KEV
Affected product: Sooil Anydana-a Firmware
Published: 2021-01-19
Last modified: 2026-06-17

Description

SOOIL Developments CoLtd DiabecareRS, AnyDana-i, AnyDana-A, The communication protocol of the insulin pump and AnyDana-i,AnyDana-A mobile apps doesn't use adequate measures to authenticate the pump before exchanging keys, which allows unauthenticated, physically proximate attackers to eavesdrop the keys and spoof the pump via BLE.

Frequently asked questions

What is CVE-2020-27272?: SOOIL Developments CoLtd DiabecareRS, AnyDana-i, AnyDana-A, The communication protocol of the insulin pump and AnyDana-i,AnyDana-A mobile apps doesn't use adequate measures to authenticate the pump before exchanging keys, which allows unauthenticated, physically proximate attackers to eavesdrop the keys and spoof the pump via BLE.
How severe is CVE-2020-27272?: CVE-2020-27272 has a CVSS 3.x base score of 5.7, rated medium severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2020-27272 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (37th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-27272?: CVE-2020-27272 primarily affects Sooil Anydana-a Firmware. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2020-27272?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2020-27272 published?: CVE-2020-27272 was published on 2021-01-19 and last updated on 2026-06-17.

References

https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01

Affected products (3)

cpe:2.3:o:sooil:anydana-a_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:sooil:anydana-i_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:sooil:diabecare_rs_firmware:*:*:*:*:*:*:*:*

More vulnerabilities in Sooil Anydana-a Firmware

CVE-2020-27264 — High (CVSS 8.8): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump…
CVE-2020-27256 — Medium (CVSS 6.8): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a hard-coded physician PIN in the physician menu…
CVE-2020-27268 — Medium (CVSS 6.5): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the…
CVE-2020-27266 — Medium (CVSS 6.5): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the…
CVE-2020-27269 — Medium (CVSS 5.7): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump…
CVE-2020-27276 — Medium (CVSS 5.7): SOOIL Developments Co Ltd DiabecareRS,AnyDana-i & AnyDana-A, the communication protocol of the insulin pump and its…

All CVEs affecting Sooil Anydana-a Firmware →